Literature DB >> 22216528

Altered distribution of digoxin in renal failure--a cause of digoxin toxicity?

J K Aronson1, D G Grahame-Smith.   

Abstract

Three cases are described in which renal failure was accompanied by a lowered apparent volume of distribution of digoxin. In two cases this resulted in frank digoxin toxicity and in one equivocal toxicity. In all three cases digoxin plasma levels were greater than 2 ng/ml. The possible causes of the abnormal distribution of digoxin in renal failure are discussed. Recommendations are outlined for the use of digoxin in patients with renal failure aimed at circumventing the problem raised by a lowered apparent volume of distribution of the drug.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 22216528      PMCID: PMC1428967          DOI: 10.1111/j.1365-2125.1976.tb00356.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE.

Authors:  J E DOHERTY; W H PERKINS; M C WILSON
Journal:  Am J Med       Date:  1964-10       Impact factor: 4.965

2.  Induction of a ouabain-sensitive ATPase defect by uremic plasma.

Authors:  C H Cole; J W Balfe; L G Welt
Journal:  Trans Assoc Am Physicians       Date:  1968

3.  Membrane transport defect: the sick cell.

Authors:  L G Welt
Journal:  Trans Assoc Am Physicians       Date:  1967

4.  The inotropic effects of digoxin in hyperkalemia. Relation to (Na+,K+)-ATPase inhibition in the intact animal.

Authors:  R H Goldman; D J Coltart; J P Friedman; G T Nola; D K Berke; E Schweizer; D C Harrison
Journal:  Circulation       Date:  1973-10       Impact factor: 29.690

5.  Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.

Authors:  R H Reuning; R A Sams; R E Notari
Journal:  J Clin Pharmacol New Drugs       Date:  1973-04

6.  The excretion of tritiated digoxin in normal human volunteers before and after unilateral nephrectomy.

Authors:  J E Doherty; W J Flanigan; R M Patterson; G V Dalrymple
Journal:  Circulation       Date:  1969-10       Impact factor: 29.690

7.  An improved method of digoxin therapy.

Authors:  R W Jelliffe
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

8.  Digitalis intoxication. A prospective clinical study with serum level correlations.

Authors:  G A Beller; T W Smith; W H Abelmann; E Haber; W B Hood
Journal:  N Engl J Med       Date:  1971-05-06       Impact factor: 91.245

9.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

10.  Estimation of volume of distribution and half-life of a compound after rapid intravenous injection.

Authors:  J G Wagner; J I Northam
Journal:  J Pharm Sci       Date:  1967-04       Impact factor: 3.534

View more
  12 in total

1.  Anecdotes as evidence.

Authors:  Jeffrey K Aronson
Journal:  BMJ       Date:  2003-06-21

Review 2.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 4.  Disease-related alterations in cardiac glycoside disposition.

Authors:  H R Ochs; D J Greenblatt; G Bodem; H J Dengler
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

6.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  Early research on renal function and drug action.

Authors:  Marcus M Reidenberg
Journal:  J Clin Pharmacol       Date:  2012-01       Impact factor: 3.126

8.  Evaluation of digoxin concentration after loading dose in patients with renal dysfunction.

Authors:  Nadia Pawlosky; Erika Macdonald; Rakesh Patel; Salmaan Kanji
Journal:  Can J Hosp Pharm       Date:  2013-03

Review 9.  Interpretation of drug levels in acute and chronic disease states.

Authors:  E Perucca; R Grimaldi; A Crema
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

Review 10.  Interpretation of the serum digoxin concentration.

Authors:  M Weintraub
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.